The wait for an effective yet non-invasive injectable cellulite treatment is over! Dr. Tatiana Khrom of Khrom Dermatology & Aesthetics in Brooklyn, NY is pleased to announce the first-ever, FDA-approved injections to soften the appearance of dreaded “dimpling”: Qwo™ by Endo Aesthetics LLC. When injected precisely into the buttocks of adult women with moderate to severe cellulite, the active ingredient in Qwo solution, collagenase clostridium histolyticum-aaes, targets and releases the fibrous septae connective tissue implicated as the primary structural factor behind the development of cellulite. The fibrous septae tether underlying fascia tissue to the skin, drawing it downward, which gives rise to the uneven, pitted surfaces that characterize cellulite.
Qwo™ is being deemed a “game-changer,” because it represents the first injectable treatment of its kind for a condition that affects more than 90% of women – of all shapes, sizes, and ethnicities. Fibrous septae have varying thickness among men, a gender variance that contributes to the obvious prevalence among women, as well as Endo Aesthetics’ understanding of cellulite. These findings informed the development of Qwo™ as a revolutionary treatment for one of the most common cosmetic conditions affecting women. As a non-invasive option, side effects are not unlike those of other non-surgical aesthetic products, including injection site firmness, swelling, discoloration, and warmth. Find out how Qwo™ may help you unleash your confidence. Call Khrom Dermatology & Aesthetics at (718) 619-4779 to schedule your consultation. Read the full article here.
Back to In the Press Page
